Penn Dental Study Finds Promising Plant-Based Hemophilia Therapy

Freeze dried lettuce containing a protein of interest. PHOTO COURTESY OF UNNIVERSITY OF PENNSLYVANIA

Researchers from University of Pennsylvania School of Dental Medicine, University of Florida and University of North Carolina have developed a therapy to prevent the development of antibodies that work against the clotting factor in patients with hemophilia. In the study, led by Henry Daniell, PhD, director of Translational Research at Penn Dental Medicine, researchers used clotting factor produced in plant cells to instruct the body to accept rather than block it. Daniell’s past research focused on implementing codon optimization to create a genetic engineering technique that persuades lettuce and tobacco plants to produce foreign proteins

In the most recent study, published in Molecular Therapy, four hemophilia B dogs were fed freeze-dried lettuce powder/clotting factor for more than 300 days; they also received weekly injections of clotting factor IX for eight weeks. The dogs in the control group that did not receive the lettuce powder developed significant levels of antibodies against clotting factor IX, as compared to the experimental group, in which three of the four dogs had only minimal levels of antibody IgG2, and no detectable levels of IgG1 or IgE. Levels of IgG2 were 32 times lower in the treated dogs than in the control group.

​​​​​​​“The results were quite dramatic,” Daniell told Penn News. “We corrected blood clotting time in each of the dogs and were able to suppress antibody formation, as well. All signs point to this material being ready for the clinic.”

The next steps for the research team include additional toxicology and pharmacokinetics studies before applying for an Investigational New Drug application with the U.S. Food and Drug Administration before the end of the year, according to Penn News. Read more at news.upenn.edu/news/plant-made-hemophilia-therapy-shows-promise-penn-study-finds

FEATURED IMAGE COURTESY OF UNIVERSITY OF PENNSYLVANIA

Add a Comment

Your email address will not be published. Required fields are marked *

The Viscardi Center And Henry Schein Announce ‘Project Accessible Oral Health’

New Coalition Aims to Shine Light on Significant Need to Enhance...

AAOMS honors oral and maxillofacial surgeons during Annual Meeting

SAN FRANCISCO, Calif. – More than 20 oral and maxillofacial surgeons...

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

WHAT Despite remarkable gains in the treatment and prevention of HIV...

Outstanding Innovators In Dentistry Honored At 15th Annual Shils Awards Ceremony

The Dr. Edward B. Shils Entrepreneurial Fund Recognizes People, Organizations, and...

LANAP and LAPIP Protocols: Laser Gum Disease Protocols

Over 50% of US adults have gum disease.  Offer your patients...

IRIS HD USB 3.0 Intraoral Camera

Experience the Clarity in High Definition The new IRIS HD USB...

A New Adhesive/Primer Ideal for Indirect Restorations

At BISCO, adhesion is our passion. BISCO prides itself on developing...

KDZ Bruxer® Aesthetic

Bring the strength of full-contour zirconia into the facial zone with...